BrightSpring Health Services, Inc. reported financial results for the third quarter ended September 30, 2026, and updated its full-year 2026 guidance. The company, which provides home- and community-based health services, noted that on March 30, 2026, it completed the divestiture of its Community Living business, with all results presented pertaining to continuing operations.
For the third quarter of 2026, BrightSpring reported net revenue of $4.213 billion, a 26.4% increase compared to the same period in 2025. The company also reported a net income from continuing operations of $101 million and Adjusted EBITDA of $228 million, representing a 42.0% increase year-over-year.
BrightSpring increased its full-year 2026 guidance, excluding the Community Living business and the effects of future closed acquisitions. The company now expects total revenues of $15.9 billion to $16.125 billion, representing growth of 23.2% to 24.9% compared to 2025. Adjusted EBITDA is expected to reach $850 million to $860 million, a growth of 37.6% to 39.3%.
Specifically, the company anticipates Pharmacy Solutions revenue of $14.0 billion to $14.2 billion and Provider Services revenue of $1.9 billion to $1.925 billion for the full year. The filing notes that the Amedisys and LHC branches acquisition is expected to contribute approximately $35 million in Adjusted EBITDA in 2026.
